4-methoxyamphetamine has been researched along with dextroamphetamine in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (44.44) | 18.7374 |
1990's | 3 (33.33) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, GM; Glennon, RA; Liebowitz, SM | 1 |
Coen, KM; Corrigall, WA; Lodge, BA; Robertson, JM | 1 |
Lodge, BA; Martin-Iverson, MT | 1 |
Winter, JC | 1 |
El Hait, MA; Green, AL | 1 |
Bach, MV; Baker, GB; Coutts, RT | 1 |
Bustamante, D; Cassels, BK; Díaz-Véliz, G; Paeile, C; Zapata-Torres, G | 1 |
Irvine, RJ; Jaehne, EJ; Salem, A | 1 |
LLOYD, JT; WALKER, DR | 1 |
9 other study(ies) available for 4-methoxyamphetamine and dextroamphetamine
Article | Year |
---|---|
Serotonin receptor affinities of psychoactive phenalkylamine analogues.
Topics: Amines; Animals; Female; Hallucinogens; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Rats; Receptors, Serotonin; Stomach; Structure-Activity Relationship | 1980 |
The reinforcing and discriminative stimulus properties of para-ethoxy- and para-methoxyamphetamine.
Topics: Amphetamines; Animals; Cocaine; Conditioning, Operant; Dextroamphetamine; Discrimination, Psychological; Hallucinogens; Male; Rats; Reinforcement Schedule; Self Administration | 1992 |
Effects of chronic treatment of rats with "designer" amphetamines on brain regional monoamines.
Topics: Amphetamines; Animals; Biogenic Monoamines; Brain; Designer Drugs; Dextroamphetamine; Hallucinogens; Male; Rats; Rats, Inbred Strains; Tissue Distribution | 1991 |
The stimulus properties of para-methoxyamphetamine: a nonessential serotonergic component.
Topics: Amphetamines; Animals; Conditioning, Operant; Dextroamphetamine; Female; Lysergic Acid Diethylamide; Mescaline; Pizotyline; Rats; Rats, Inbred Strains; Serotonin | 1984 |
A new approach to the assessment of the potency of reversible monoamine oxidase inhibitors in vivo, and its application to (+)-amphetamine, p-methoxyamphetamine and harmaline.
Topics: Alkaloids; Amphetamines; Animals; Brain; Dextroamphetamine; Harmaline; Kinetics; Male; Mitochondria; Monoamine Oxidase Inhibitors; Phenelzine; Rats; Serotonin; Tranylcypromine | 1980 |
Involvement of CYP2D6 in the in vitro metabolism of amphetamine, two N-alkylamphetamines and their 4-methoxylated derivatives.
Topics: Amphetamine; Amphetamines; Catalysis; Cytochrome P-450 CYP2D6; Dextroamphetamine; Humans; Hydroxylation; Inactivation, Metabolic; Kinetics; Microsomes; NADP; Oxidation-Reduction; Structure-Activity Relationship | 1999 |
Analgesic and behavioral effects of amphetamine enantiomers, p-methoxyamphetamine and n-alkyl-p-methoxyamphetamine derivatives.
Topics: Amphetamine; Amphetamines; Analgesics; Animals; Avoidance Learning; Behavior, Animal; Dextroamphetamine; Female; Grooming; Male; Motor Activity; Pain Measurement; Rats; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship | 2004 |
Effects of 3,4-methylenedioxymethamphetamine and related amphetamines on autonomic and behavioral thermoregulation.
Topics: Amphetamines; Analysis of Variance; Animals; Behavior, Animal; Body Temperature; Dextroamphetamine; Heart Rate; Male; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Temperature; Time Factors | 2005 |
DEATH AFTER COMBINED DEXAMPHETAMINE AND PHENELZINE.
Topics: Cerebral Hemorrhage; Death; Depression; Depressive Disorder; Dextroamphetamine; Drug Therapy; Hypertension; Mortality; Phenelzine; Toxicology; Trifluoperazine | 1965 |